Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,935 | 845 | 99.2% |
| Education | $108.25 | 4 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,798 | 119 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,635 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,456 | 83 | $0 (2024) |
| Lilly USA, LLC | $1,312 | 76 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,116 | 63 | $0 (2024) |
| ABBVIE INC. | $702.77 | 39 | $0 (2024) |
| PFIZER INC. | $665.70 | 46 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $566.77 | 34 | $0 (2022) |
| Amgen Inc. | $555.74 | 26 | $0 (2023) |
| Amarin Pharma Inc. | $512.94 | 54 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,005 | 99 | Novo Nordisk Inc ($415.40) |
| 2023 | $2,116 | 105 | Novo Nordisk Inc ($335.22) |
| 2022 | $1,965 | 112 | Novo Nordisk Inc ($304.19) |
| 2021 | $2,129 | 135 | GlaxoSmithKline, LLC. ($301.42) |
| 2020 | $1,325 | 83 | GlaxoSmithKline, LLC. ($278.69) |
| 2019 | $1,329 | 96 | GlaxoSmithKline, LLC. ($360.69) |
| 2018 | $1,440 | 94 | AstraZeneca Pharmaceuticals LP ($215.30) |
| 2017 | $1,735 | 125 | Novo Nordisk Inc ($434.73) |
All Payment Transactions
849 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Biological | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: VACCINES | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Biological | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Biological | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: Biological | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardio-renal | ||||||
| 09/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 466 | 607 | $69,885 | $24,317 |
| 2022 | 10 | 560 | 696 | $77,650 | $29,711 |
| 2021 | 11 | 615 | 732 | $78,555 | $42,521 |
| 2020 | 12 | 541 | 691 | $76,870 | $31,019 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 253 | $37,950 | $10,600 | 27.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 51 | 53 | $4,505 | $3,809 | 84.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $14,400 | $3,625 | 25.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 62 | 66 | $3,300 | $2,115 | 64.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,740 | $1,827 | 48.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 78 | 78 | $2,340 | $1,504 | 64.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 61 | 61 | $3,000 | $554.30 | 18.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 12 | 13 | $650.00 | $283.08 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 251 | $37,160 | $11,166 | 30.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 97 | 97 | $19,400 | $5,401 | 27.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 45 | 45 | $3,755 | $3,081 | 82.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $4,620 | $2,329 | 50.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 16 | 16 | $2,640 | $2,118 | 80.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 103 | 103 | $3,090 | $2,014 | 65.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 60 | 61 | $2,630 | $1,875 | 71.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 25 | $835.00 | $716.98 | 85.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 66 | 69 | $2,770 | $695.14 | 25.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 15 | $750.00 | $315.79 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 103 | 103 | $20,600 | $14,749 | 71.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 236 | $35,400 | $13,909 | 39.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 54 | 54 | $4,320 | $3,524 | 81.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 16 | 16 | $4,880 | $2,697 | 55.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 112 | 112 | $3,360 | $2,279 | 67.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 16 | 16 | $2,390 | $1,979 | 82.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 77 | 80 | $2,395 | $1,456 | 60.8% |
About Dr. Adam Pasternack, DO
Dr. Adam Pasternack, DO is a Family Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518919281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Pasternack, DO has received a total of $14,044 in payments from pharmaceutical and medical device companies, with $2,005 received in 2024. These payments were reported across 849 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($13,935).
As a Medicare-enrolled provider, Pasternack has provided services to 2,182 Medicare beneficiaries, totaling 2,726 services with total Medicare billing of $127,568. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Philadelphia, PA
- Active Since 05/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518919281
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,047
- JARDIANCE (Drug) $828.92
- FARXIGA (Drug) $816.39
- Ozempic (Drug) $647.51
- MOUNJARO (Drug) $567.17
- Vascepa (Drug) $512.94
- Rybelsus (Drug) $481.02
- TRULICITY (Drug) $422.35
- Victoza (Drug) $369.93
- Kerendia (Drug) $344.00
- UBRELVY (Drug) $331.82
- XIFAXAN (Drug) $280.15
- CHANTIX (Drug) $260.13
- Otezla (Drug) $256.12
- XARELTO (Drug) $244.51
- VRAYLAR (Drug) $232.96
- SOLIQUA (Drug) $197.49
- GVOKE HYPOPEN (Drug) $196.43
- BREZTRI (Drug) $194.69
- ANORO (Drug) $187.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Philadelphia
Dr. Michael Attanasio, D.o, D.O
Family Medicine — Payments: $263,805
Dr. Deborah Witt, M.d, M.D
Family Medicine — Payments: $226,164
Jonah Mink, Md, MD
Family Medicine — Payments: $146,427
Celia Ezidiegwu, Md, MD
Family Medicine — Payments: $117,796
Dr. Glenn Rosen, Md, MD
Family Medicine — Payments: $77,390
Dr. Casey Lafferty, D.o, D.O
Family Medicine — Payments: $54,627